By Aveek Bhowmik Elon Musk’s brain-implant company Neuralink has received a green light from the Food and Drug Administration to commence its “first-in-human clinical study.” This milestone achievement for Neuralink comes after a series of setbacks and challenges faced by the company in its pursuit of FDA approval. Neuralink logo displayed on a phone screen, […]
